Reata Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Reata Pharmaceuticals

08/11/2021 14:32

* Reata Pharmaceuticals Inc  RETA.OQ  reported a quarterly
adjusted loss of $1.97​​ per share for the quarter ended in
September. The mean expectation of nine analysts for the quarter
was for a loss of $2.16 per share.
* Revenue rose 427.6% to $7.39 million from a year ago; 
analysts expected $2.07 million. 
* Reata Pharmaceuticals Inc's reported EPS for the quarter was a
loss of $1.97​.
* The mean earnings estimate of analysts had risen by about 2.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Reata Pharmaceuticals Inc shares had risen by 4.7% this
quarter and lost 14.8% so far this year.
* The company reported a quarterly loss of $71.85 million.
* Wall Street's median 12-month price target for Reata
Pharmaceuticals Inc is $230.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated